HIGHBRIDGE CAPITAL MANAGEMENT LLC - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 23 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,217,315
+202.0%
26,500,000
+278.6%
0.72%
+184.9%
Q2 2023$5,700,520
+27064.7%
7,000,000
-67.3%
0.25%
-67.5%
Q1 2023$20,985
+128.6%
21,382,000
+112.1%
0.77%
+205.1%
Q4 2022$9,181
-99.9%
10,082,000
-32.8%
0.25%
+17.7%
Q3 2022$15,310,000
-19.5%
15,000,000
-21.1%
0.22%
-50.3%
Q2 2022$19,009,000
-4.8%
19,000,0000.0%0.43%
-6.9%
Q1 2022$19,967,00019,000,0000.46%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Perceptive Advisors 45,000,000$474,089,0009.50%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,000,000$4,280,0000.96%
DeepCurrents Investment Group LLC 22,150,000$23,650,0000.74%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 19,000,000$19,967,0000.46%
Context Capital Management, LLC 5,750$6,138,0000.40%
WOLVERINE ASSET MANAGEMENT LLC 34,000,000$36,271,0000.35%
Polar Asset Management Partners Inc. 15,000,000$15,993,0000.17%
LINDEN ADVISORS LP 20,000,000$21,281,0000.13%
Wellesley Asset Management 1,599$1,599,0000.11%
Verition Fund Management LLC 6,213,000$6,614,0000.08%
View complete list of TRAVERE THERAPEUTICS INC shareholders